Answers are grounded in this paper and cite their sources.
AIM: This study presents a bibliometric analysis of research trends and emerging hotspots in upconversion nanoparticles (UCNPs) for drug delivery and biomedical targeting in photodynamic therapy (PDT). METHODS: We retrieved 474 publications from the Web of Science (2007-2025) and analyzed publication trends, contributions from countries, institutions, and authors, keyword co-occurrence, citation bursts, and co-citation networks using CiteSpace, VOSviewer, HistCite, and R software. RESULTS: UCNP-PDT research progressed through three distinct phases, with China and the USA contributing the most publications. Nanoscale published the highest number of articles, while high-impact reviews appeared in Chemical Society Reviews and Advanced Materials. Emerging research focuses include the tumor microenvironment, metal-organic frameworks, combination therapies, and antimicrobial PDT. CONCLUSION: UCNP-PDT has evolved from simple photosensitizer loading to multifunctional nanoplatforms, expanding applications to cancer therapy, infection control, and immune modulation. Clinical translation remains limited by size-efficiency trade-offs, low-power irradiation, hypoxia, tissue heating under 980 nm excitation, GMP-compliant production, and insufficient long-term biosafety data. Future advances require coordinated strategies integrating material optimization, mechanistic insight, and translational considerations to achieve safe, scalable, and effective UCNP-PDT for clinical use.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: